We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Protagen Partners with the National Cancer Institute for Biomarker Research

News   Feb 03, 2017 | Original Story From Protagen

 
Protagen Partners with the National Cancer Institute for Biomarker Research
 
 
 

RELATED ARTICLES

Tiny Protein Could Play Huge Role in Treatment of Duchenne Muscular Dystrophy

News

A new multi-institution study suggests a tiny protein could play a major role in combating heart failure related to Duchenne muscular dystrophy, the most common lethal genetic disorder among children.

READ MORE

Cancer-killing Virus Gives Immunotherapy a Helping Hand Tackling Hard-to-treat Cancer

News

Combining a cancer-killing virus with immunotherapy could effectively treat advanced cancers that affect the limbs, a new study reveals.

READ MORE

Artificial Nose Helps Neurosurgeons Identify Cancerous Tissue During Surgery

News

Scientists have developed an artificial nose, which can help neurosurgeons identify cancerous tissue during surgery and enables the more precise excision of tumors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE